<p>1. The Global Public Health Significance of Plasmodium vivax</p> <p>Simon I. Hay, Peter W. Gething, Iqbal R. F. Elyazar, Ric N. Price and J. Kevin Baird </p> <p>2. Plasmodium vivax Biology: The Life Strategies of a Persistent Parasite</p> <p>John W. Barnwell, Esmeralda V. S. Meyer and Mary R. Galinski </p> <p>3. Plasmodium vivax Relapse: Biology, Epidemiology, and Therapeutic Implications</p> <p>Nicholas J. White and M. Imwong </p> <p>4. The Clinical Medicine of Plasmodium vivax</p> <p>Nicholas M. Anstey, Nicholas M. Douglas, Jeanne Rini Poespoprodjo and Ric N. Price </p> <p>5. Plasmodium vivax Malaria Therapy for Neurosyphilis</p> <p>Georges Snounou and Jean-Louis Pérignon </p> <p>6. Resistance to Plasmodium vivax</p> <p>Peter A. Zimmerman, Marcelo Urbano Ferreira, Rosalind E. Howes and Odile Mercereau-Puijalon </p> <p>7. Natural Acquisition of Immunity to P. vivax: Epidemiological Observations and Potential Targets</p> <p>Ivo Mueller, Mary R. Galinski, Myriam Arevalo-Herrera, Takafumi Tsuboi and Christopher L. King </p> <p>8. Diagnosis and Treatment of Plasmodium vivax Infections</p> <p>J. Kevin Baird, Jason D Maguire and Ric N. Price </p> <p>9. G6PD Deficiency: Global Distribution, Genetic Variants and Primaquine Therapy</p> <p>Rosalind E. Howes, Ari W. Satyagraha, Lucio Luzzatto, J. Kevin Baird and Simon I. Hay </p> <p>10. The Epidemiology of Plasmodium vivax</p> <p>David L. Smith, Christinah Chiyaka, Simon I. Hay and F. Ellis McKenzie </p> <p>11. The Genomics, Population Genetics and Evolutionary History of Plasmodium vivax</p> <p>Jane M. Carlton, Aparup Das and Ananias Escalante </p> <p>12. Reducing Transmission of Plasmodium vivax Malaria Using Antimalarial Drugs</p> <p>Nicholas M. Douglas, George K. John, Lorenz von Seidlein, Nicholas M. Anstey and Ric N. Price </p> <p>13. Control and Elimination of Plasmodium vivax</p> <p>G. Dennis Shanks</p>